لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Hessol NA, Priddy FH, Bolan G, Baumrind N, Vittinghoff E, Reingold AL, Padian NS, Hessol, N A, Priddy, F H, Bolan, G, Baumrind, N, Vittinghoff, E, Reingold, A L, Padian, N S

المصدر: Sexually Transmitted Diseases; Mar/Apr96, Vol. 23 Issue 2, p157-163, 7p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Lavender B; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand., Hooker C; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand., Frampton C; University of Otago, 2 Riccarton Ave, Christchurch 8011, New Zealand., Williams M; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand., Carson S; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand., Paterson A; School of Medical Sciences, The University of Auckland, 2 Park Rd, Grafton, Auckland 1023, New Zealand., McGregor R; School of Medical Sciences, The University of Auckland, 2 Park Rd, Grafton, Auckland 1023, New Zealand., Moreland NJ; School of Medical Sciences, The University of Auckland, 2 Park Rd, Grafton, Auckland 1023, New Zealand., Gell K; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand., Priddy FH; Independent Consultant., Wiig K; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand., Le Gros G; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand., Ussher JE; Vaccine Alliance Aotearoa New Zealand and University of Otago, 362 Leith St, Dunedin 9016, New Zealand., Brewerton M; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand; Department of Clinical Immunology & Allergy, Auckland City Hospital, 2 Park Rd, Grafton, Auckland 1023, New Zealand. Electronic address: blavender@malaghan.org.nz.

المصدر: Vaccine [Vaccine] 2023 Aug 31; Vol. 41 (38), pp. 5535-5544. Date of Electronic Publication: 2023 Jul 27.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: BNT162 Vaccine* , COVID-19*/epidemiology , COVID-19*/prevention & control, Adult ; Humans ; Antibodies, Neutralizing ; Antibodies, Viral ; COVID-19 Vaccines ; Immunoglobulin G ; Maori People ; New Zealand/epidemiology ; SARS-CoV-2 ; Vaccination ; Middle Aged ; Pacific Island People ; Immunogenicity, Vaccine

SCR Protocol: COVID-19 vaccine booster shot

SCR Organism: SARS-CoV-2 variants

المؤلفون: Priddy FH; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand. Electronic address: fpriddy@malaghan.org.nz., Williams M; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand., Carson S; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand., Lavender B; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand., Mathieson J; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand., Frampton C; University of Otago, 2 Riccarton Ave, Christchurch 8011, New Zealand., Moreland NJ; University of Auckland, 2 Park Rd, Grafton Auckland 1023, New Zealand., McGregor R; University of Auckland, 2 Park Rd, Grafton Auckland 1023, New Zealand., Williams G; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand., Brewerton M; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand; Department of Clinical Immunology & Allergy, Auckland City Hospital, 2 Park Rd, Grafton Auckland 1023, New Zealand., Gell K; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand., Ussher J; Vaccine Alliance Aotearoa New Zealand and University of Otago, 362 Leith St, Dunedin 9016 New Zealand., Le Gros G; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand.

المصدر: Vaccine [Vaccine] 2022 Aug 12; Vol. 40 (34), pp. 5050-5059. Date of Electronic Publication: 2022 Jul 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19 Vaccines*, Aged ; Antibodies, Neutralizing ; Antibodies, Viral ; BNT162 Vaccine ; Female ; Humans ; Immunogenicity, Vaccine ; Immunoglobulin G ; Male ; Middle Aged ; New Zealand/epidemiology ; Prospective Studies ; SARS-CoV-2 ; Vaccines, Synthetic ; mRNA Vaccines

المؤلفون: Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Julg B; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA., Tan CS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA., Zash R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA., Walsh SR; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Rolle CP; Orlando Immunology Center, Orlando, FL, USA., Monczor AN; McGovern Medical School at The University of Texas Health Science Center, Houston, TX, USA., Lupo S; McGovern Medical School at The University of Texas Health Science Center, Houston, TX, USA., Gelderblom HC; International AIDS Vaccine Initiative, New York, NY, USA., Ansel JL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Kanjilal DG; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Maxfield LF; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Nkolola J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Borducchi EN; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Abbink P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Liu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Chandrashekar A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Nityanandam R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Lin Z; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Setaro A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Sapiente J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Chen Z; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Sunner L; International AIDS Vaccine Initiative, New York, NY, USA., Cassidy T; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA., Bennett C; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Sato A; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Mayer B; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Perelson AS; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA., deCamp A; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Priddy FH; International AIDS Vaccine Initiative, New York, NY, USA., Wagh K; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA., Giorgi EE; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA., Yates NL; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Departments of Surgery, Immunology and Molecular Genetics and Microbiology, Duke University, Durham, NC, USA., Arduino RC; McGovern Medical School at The University of Texas Health Science Center, Houston, TX, USA., DeJesus E; Orlando Immunology Center, Orlando, FL, USA., Tomaras GD; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Departments of Surgery, Immunology and Molecular Genetics and Microbiology, Duke University, Durham, NC, USA., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Korber B; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; New Mexico Consortium, Los Alamos, NM, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.

المصدر: Nature medicine [Nat Med] 2021 Oct; Vol. 27 (10), pp. 1718-1724. Date of Electronic Publication: 2021 Oct 07.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*administration & dosage , Broadly Neutralizing Antibodies/*administration & dosage , HIV Infections/*drug therapy , HIV-1/*drug effects, Adult ; Antiretroviral Therapy, Highly Active ; Antiviral Agents/immunology ; Antiviral Agents/pharmacokinetics ; Broadly Neutralizing Antibodies/immunology ; CD4-Positive T-Lymphocytes/drug effects ; CD4-Positive T-Lymphocytes/virology ; Double-Blind Method ; Female ; HIV Envelope Protein gp120/antagonists & inhibitors ; HIV Envelope Protein gp120/immunology ; HIV Infections/genetics ; HIV Infections/pathology ; HIV Infections/virology ; HIV-1/pathogenicity ; Humans ; Male ; Middle Aged ; Peptide Fragments/antagonists & inhibitors ; Peptide Fragments/immunology ; Placebos ; Viral Load/drug effects ; Viral Load/immunology ; Young Adult

المؤلفون: Koff WC; Human Vaccines Project, New York, NY 10119, USA. wkoff@humanvaccinesproject.org.; Human Immunomics Initiative, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA., Schenkelberg T; Human Vaccines Project, New York, NY 10119, USA.; Human Immunomics Initiative, Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA 02115, USA., Williams T; Department of Pathology, Albert Einstein College of Medicine Bronx, NY 10461, USA., Baric RS; Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA., McDermott A; Vaccine Immunology Program, Vaccine Research Center, National Institutes of Health, Bethesda, MD 20814, USA., Cameron CM; School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA., Cameron MJ; School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA., Friemann MB; Department of Microbiology and Immunology, University of Maryland at Baltimore, Baltimore, MD School of Medicine, Baltimore, MD 21201, USA., Neumann G; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA., Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA.; Institute of Medical Science, University of Tokyo, Bunkyo City, Tokyo 113-8654, Japan., Kelvin AA; Departments of Pediatrics, Microbiology and Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada., Ross TM; Animal Health Research Center, Center for Vaccines, Immunology and Infectious Disease, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA., Schultz-Cherry S; Infectious Diseases Research, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Mastro TD; FHI 360, Durham, NC 27701, USA., Priddy FH; Vaccine Alliance Aotearoa New Zealand, Malaghan Institute of Medical Research, Wellington 6242, New Zealand., Moore KA; Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis MN 55455, USA., Ostrowsky JT; Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis MN 55455, USA., Osterholm MT; Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota, Minneapolis MN 55455, USA., Goudsmit J; Human Vaccines Project, New York, NY 10119, USA.; Human Immunomics Initiative, Departments of Epidemiology, Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.

المصدر: Science translational medicine [Sci Transl Med] 2021 Feb 03; Vol. 13 (579).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Disease Susceptibility*, COVID-19/*immunology , COVID-19/*virology , COVID-19 Vaccines/*immunology , SARS-CoV-2/*physiology, Animals ; COVID-19 Vaccines/adverse effects ; Disease Models, Animal ; Humans ; Phylogeny

المؤلفون: Priddy FH; International AIDS Vaccine Initiative, New York, NY, USA. Electronic address: fpriddy@iavi.org., Lewis DJM; NIHR Imperial Clinical Research Facility, Imperial College, London UK., Gelderblom HC; International AIDS Vaccine Initiative, New York, NY, USA., Hassanin H; Surrey Clinical Research Centre, University of Surrey, Guildford, UK., Streatfield C; International AIDS Vaccine Initiative, London, UK., LaBranche C; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Hare J; International AIDS Vaccine Initiative, London, UK., Cox JH; International AIDS Vaccine Initiative, New York, NY, USA., Dally L; The Emmes Company, LLC, Rockville, MD, USA., Bendel D; Surrey Clinical Research Centre, University of Surrey, Guildford, UK., Montefiori D; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Sayeed E; International AIDS Vaccine Initiative, New York, NY, USA., Ackland J; Global Biosolutions, Melbourne, Australia., Gilmour J; International AIDS Vaccine Initiative, London, UK., Schnepp BC; Children's Hospital of Philadelphia., Wright JF; Children's Hospital of Philadelphia., Johnson P; Children's Hospital of Philadelphia.

المصدر: The lancet. HIV [Lancet HIV] 2019 Apr; Vol. 6 (4), pp. e230-e239. Date of Electronic Publication: 2019 Mar 15.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Vectors*, Antibodies, Neutralizing/*blood , Dependovirus/*genetics , Genetic Therapy/*methods , HIV Antibodies/*blood , HIV Infections/*prevention & control, Adolescent ; Adult ; Antibodies, Neutralizing/genetics ; Double-Blind Method ; Follow-Up Studies ; Genetic Therapy/adverse effects ; HIV Antibodies/genetics ; Healthy Volunteers ; Humans ; Injections, Intramuscular ; Male ; Middle Aged ; Neutralization Tests ; Placebos/administration & dosage ; Recombinant Proteins/blood ; Recombinant Proteins/genetics ; United Kingdom ; Young Adult

المؤلفون: Mugo PM; Center for Geographic Medicine - Coast, Kenya Medical Research Institute, Kilifi, Kenya, pmugo@kemri-wellcome.org., Sanders EJ, Mutua G, van der Elst E, Anzala O, Barin B, Bangsberg DR, Priddy FH, Haberer JE

المصدر: AIDS and behavior [AIDS Behav] 2015 May; Vol. 19 (5), pp. 794-801.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE

مواضيع طبية MeSH: Homosexuality, Male*, Anti-HIV Agents/*administration & dosage , Emtricitabine/*administration & dosage , HIV Infections/*prevention & control , Medication Adherence/*statistics & numerical data , Pre-Exposure Prophylaxis/*methods , Tenofovir/*administration & dosage, Administration, Oral ; Anti-HIV Agents/therapeutic use ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Emtricitabine/therapeutic use ; Female ; HIV Infections/drug therapy ; Humans ; Kenya ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Socioeconomic Factors ; Tenofovir/therapeutic use